Skip to main content
. 2017 Jun 8;14(2):1711–1718. doi: 10.3892/ol.2017.6345

Figure 2.

Figure 2.

Representative images of immunohistochemical analysis of the expression patterns of FOXP3 in different tumors. Magnification, ×200. (A) Hematoxylin and eosin staining in tumor tissues of patients with DLBCL. (B) Expression of FOXP3 in tumor tissues of patients with DLBCL. (C) Expression of FOXP3 in adjacent tissues of patients with DLBCL. (D) The increased expression of FOXP3 is a factor associated with poor prognosis of patients with DLBCL. DLBCL, diffuse large B-cell lymphoma; FOXP3, forkhead box P3.